PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF LUMASIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC FOR PRIMARY HYPEROXALURIA TYPE

被引：0
|
作者：
Habtemariam, B. [1 ]
Attarwala, H. [1 ]
Cao, K. [1 ]
Clausen, V. [1 ]
Goel, V. [1 ]
Melch, M. [1 ]
McGregor, T. L. [1 ]
Robbie, G. J. [1 ]
机构：
[1] Alnylam Pharmaceut, Cambridge, MA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2019年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
LB-019
引用
收藏
页码：S37 / S37
页数：1
相关论文
共 50 条
  • [31] EFFICACY AND SAFETY OF LUMASIRAN IN PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1: 24-MONTH ANALYSIS OF THE ILLUMINATE-A TRIAL
    Lieske, John
    Groothoff, Jaap
    Frishberg, Yaacov
    Sellier-Leclerc, Anne-Laure
    Shasha-Lavsky, Hadas
    Saland, Jeffrey
    Hayes, Wesley
    Magen, Daniella
    Moochhala, Shabbir
    Coenen, Martin
    Simkova, Eva
    Ngo, Taylor
    Gansner, John
    Hulton, Sally-Anne
    JOURNAL OF UROLOGY, 2022, 207 (05): : E87 - E87
  • [32] THE OUTCOME OF LUMASIRAN TREATMENT IN 10 PAEDIATRIC PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1
    Saffe, Sina
    Buescher, Anja
    Doerry, Katja
    Habbig, Sandra
    Hansen, Matthias
    John-Kroegel, Ulrike
    Kanzelmeyer, Nele
    Latta, Kay
    Oh, Jun
    Kemper, Markus
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I213 - I213
  • [33] EFFECT OF LUMASIRAN ON KIDNEY STONES AND NEPHROCALCINOSIS IN PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1
    Lieske, John C.
    Garrelfs, Sander F.
    Michael, Mini
    Saland, Jeffrey M.
    Sas, David J.
    Ngo, Taylor
    Gansner, John M.
    McGregor, Tracy L.
    Frishberg, Yaacov
    JOURNAL OF UROLOGY, 2021, 206 : E142 - E142
  • [34] EFFICACY AND SAFETY OF LUMASIRAN IN PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1: 36-MONTH ANALYSIS OF THE ILLUMINATE-A TRIAL
    Lieske, John
    Saland, Jeffrey
    Groothoff, Jaap
    Frishberg, Yaacov
    Shasha-Lavsky, Hadas
    Magen, Daniella
    Moochhala, Shabbir
    Simkova, Eva
    Coenen, Martin
    Hayes, Wesley
    Hogan, Julien
    Sellier-Leclerc, Anne-Laure
    Bao, Yinggu
    Gansner, John
    Hulton, Sally-Anne
    JOURNAL OF UROLOGY, 2023, 209 : E114 - E114
  • [35] EFFICACY AND SAFETY OF LUMASIRAN IN PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1: 24-MONTH ANALYSIS OF THE ILLUMINATE-A TRIAL
    Lieske, John
    Groothoff, Jaap
    Frishberg, Yaacov
    Sellier-Leclerc, Anne-Laure
    Shasha-Lavsky, Hadas
    Saland, Jeffrey
    Hayes, Wesley
    Magen, Daniella
    Moochhala, Shabbir
    Coenen, Martin
    Simkova, Eva
    Ngo, Taylor
    Gansner, John
    Hulton, Sally-Anne
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (04) : S1 - S2
  • [36] EFFICACY AND SAFETY OF LUMASIRAN IN PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1: 36-MONTH ANALYSIS OF THE ILLUMINATE-A TRIAL
    Saland, Jeffrey
    Lieske, John
    Groothoff, Jaap
    Frishberg, Yaacov
    Shasha-Lavsky, Hadas
    Magen, Daniella
    Moochhala, Shabbir
    Simkova, Eva
    Coenen, Martin
    Hayes, Wesley
    Hogan, Julien
    Sellier-Leclerc, Anne-Laure
    Bao, Yinggu
    Gansner, John
    Hulton, Sally-Anne
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S56 - S57
  • [37] Relationship of baseline weight and response to lumasiran in patients with primary hyperoxaluria type 1 on hemodialysis
    Michael, Mini
    Groothoff, Jaap
    Shasha-Lavsky, Hadas
    Lieske, John
    Yaacov, Frishberg
    Simkova, Eva
    Sellier-Leclerc, Anne-Laure
    Devresse, Arnaud
    Guebre-Egziabher, Fitsum
    Bakkaloglu, Sevcan
    Mourani, Chebl
    Saqan, Rola
    Singer, Richard
    Gansner, John
    Magen, Daniella
    PEDIATRIC NEPHROLOGY, 2023, 38 (07) : 2293 - 2293
  • [38] Glycolate oxidase inhibition by lumasiran varies between patients with primary hyperoxaluria type 1
    Garrelfs, Sander F.
    Metry, Elisabeth L.
    van Harskamp, Dewi
    Vaz, Frederic M.
    van den Akker, Chris H. P.
    Schierbeek, Henk
    Groothoff, Jaap W.
    Oosterveld, Michiel J. S.
    KIDNEY INTERNATIONAL, 2023, 103 (05) : 990 - 993
  • [39] Less Is More: A Case of Isolated Kidney Transplantation with Lumasiran in Primary Hyperoxaluria Type 1
    Ice, Alissa Angelica
    Azam, Muhammad Jibran
    Langone, Anthony J.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [40] IMPACT OF BASELINE URINARY OXALATE ON RESPONSE TO LUMASIRAN IN PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1
    Sas, David
    Bacchetta, Justine
    Ngo, Taylor
    Gansner, John
    Brown, Thomas
    Garrelfs, Sander
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (04) : S9 - S9
12345